Here, we applied RNA-seq in full-thickness aortic biopsies from two groups of patients with MFS, with either haploinsufficient (n = 3) or dominant negative (n = 3) FBN1 variants, to determine the molecular mechanisms affected by these two variant types. This evidence concerns the gene FBN1 and Marfan syndrome.